ANN ARBOR STAGE II ADULT LYMPHOBLASTIC LYMPHOMA

Clinical trials for ANN ARBOR STAGE II ADULT LYMPHOBLASTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ANN ARBOR STAGE II ADULT LYMPHOBLASTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for ANN ARBOR STAGE II ADULT LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial seeks better treatment for aggressive childhood cancers

Disease control Ongoing

This large, late-stage trial is testing whether adding a drug called bortezomib to standard chemotherapy works better for treating newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LLy). The study involves 847 children and young adul…

Matched conditions: ANN ARBOR STAGE II ADULT LYMPHOBLASTIC LYMPHOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

ANN ARBOR STAGE II ADULT LYMPHOBLASTIC LYMPHOMA

Get alerted when new ANN ARBOR STAGE II ADULT LYMPHOBLASTIC LYMPHOMA trials appear

Major trial seeks better treatment for aggressive childhood cancers